Rituximab-associated HBV Reactivation in Lymphoma Patients with Resolved Hepatitis B: Kinetics of Anti-HBs Titers with or without Entecavir Prophylaxis

被引：0
|
作者：
Huang, Yi-Hsiang [1 ,2 ]
Lee, I-Cheng [1 ,2 ]
Hsiao, Liang-Tsai [3 ]
Lin, Han-Chieh [1 ]
Lee, Shou-Dong [4 ]
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Div Hematol & Oncol, Taipei, Taiwan
[4] Cheng Hsin Gen Hosp, Taipei, Taiwan
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
932
引用
收藏
页码：652A / 652A
页数：1
相关论文
共 50 条
  • [21] Detection of recurrent hepatitis B after OLT in patients treated with HBIG prophylaxis using graft-biopsy staining, anti-HBs titers and hepatitis B serology
    Nymann, T
    Adamec, T
    ShokouhAmiri, MH
    Vera, SR
    Gaber, AO
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 507 - 508
  • [22] Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient
    Awerkiew, Sabine
    Daeumer, Martin
    Reiser, Marcel
    Wend, Ulrike C.
    Pfister, Herbert
    Kaiser, Rolf
    Willems, Wulf R.
    Gerlich, Wolfram H.
    JOURNAL OF CLINICAL VIROLOGY, 2007, 38 (01) : 83 - 86
  • [23] Is Antiviral Prophylaxis Necessary to Prevent Hepatitis B Virus (HBV) Reactivation in Patients With HBV-Resolved Infection Receiving Rituximab-Containing Chemotherapy?
    Kusumoto, Shigeru
    Tanaka, Yasuhito
    Mizokami, Masashi
    Ueda, Ryuzo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) : 4480 - 4480
  • [24] PROSPECTIVE STUDY OF HEPATITIS B VIRUS REACTIVATION IN HBSAG-NEGATIVE PATIENTS AFTER CHEMOTHERAPY WITH RITUXIMAB: HBV-DNA MONITORING AND ENTECAVIR PROPHYLAXIS
    Kojima, H.
    Tsujimura, H.
    Mimura, N.
    Sugawara, T.
    Ise, M.
    Sakai, C.
    Yamada, S.
    Miyaki, T.
    Kumagai, K.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S292 - S292
  • [25] PROSPECTIVE STUDY OF HEPATITIS B VIRUS REACTIVATION IN HBSAG-NEGATIVE PATIENTS AFTER CHEMOTHERAPY WITH RITUXIMAB: HBV-DNA MONITORING AND ENTECAVIR PROPHYLAXIS
    Kojima, H.
    Tsujimura, H.
    Sugawara, T.
    Mimura, N.
    Ise, M.
    Sakai, C.
    Yamada, S.
    Miyaki, T.
    Kumagai, K.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S206 - S206
  • [26] Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab
    Tan, Chia Jie
    Kumar, Rajneesh
    Koomanan, Narendran
    Loo, Wei Sheng
    Farid, Mohamad
    Tao, Miriam
    Somasundaram, Nagavalli
    Poon, Eileen
    Chan, Jason Yongsheng
    Yang, Valerie Shiwen
    Chang, Esther
    Lim, Soon Thye
    Chow, Wan Cheng
    Chan, Alexandre
    Tang, Tiffany
    PHARMACOTHERAPY, 2021, 41 (04): : 332 - 341
  • [27] A Case of Hepatitis B Reactivation in an Anti-HBs Positive,Anti-HBc Positive non-Hodgkin’s Lymphoma Patient
    Chunchen Wu
    Hui Shi
    Mengji Lu
    Yang Xu
    Xinwen Chen
    Virologica Sinica, 2013, (01) : 49 - 53
  • [28] A Case of Hepatitis B Reactivation in an Anti-HBs Positive,Anti-HBc Positive non-Hodgkin’s Lymphoma Patient
    Chunchen Wu
    Hui Shi
    Mengji Lu
    Yang Xu
    Xinwen Chen
    Virologica Sinica, 2013, 28 (01) : 49 - 53
  • [29] Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports
    Evens, A. M.
    Jovanovic, B. D.
    Su, Y. -C.
    Raisch, D. W.
    Ganger, D.
    Belknap, S. M.
    Dai, M. -S.
    Chiu, B. -C. C.
    Fintel, B.
    Cheng, Y.
    Chuang, S. -S.
    Lee, M. -Y.
    Chen, T. -Y.
    Lin, S. -F.
    Kuo, C. -Y.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1170 - 1180
  • [30] Is Antiviral Prophylaxis Necessary to Prevent Hepatitis B Virus (HBV) Reactivation in Patients With HBV-Resolved Infection Receiving Rituximab-Containing Chemotherapy? Reply
    Huang, Yi-Hsiang
    Lin, Han-Chieh
    Lee, Shou-Dong
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (35) : 4481 - 4481
12345